Archer, J. R. H., Dargan, P. I., Lostia, A. M., van der Walt, J., Henderson, K., Drake, N., . . . Kicman, A. T. (2015). Running an unknown risk: A marathon death associated with the use of 1,3-dimethylamylamine (DMAA). Drug Testing and Analysis, 7(5), 433–438. doi:10.1002/dta.1764
Austin, K. G., Travis, J., Pace, G., & Lieberman, H. R. (2014). Analysis of 1,3 dimethylamylamine concentrations in Geraniaceae, geranium oil and dietary supplements. Drug Testing and Analysis, 6(7-8), 797–804. doi:10.1002/dta.1491
Bloomer, R. J., Harvey, I. C., Farney, T. M., Bell, Z. W., & Canale, R. E. (2015). Effects of 1,3-dimethylamylamine and caffeine alone or in combination on heart rate and blood pressure in healthy men and women. The Physician and Sportsmedicine, 39(3), 111–120. doi:10.3810/psm.2011.09.1927
Brown, J. A., & Buckley, N. A. (2013). Toxicity from bodybuilding supplements and recreational use of products containing 1,3-dimethylamylamine. Medical Journal of Australia, 198(8), 414–415. doi:10.5694/mja12.11167
Cohen, P. A., Travis, J. C., Keizers, P. H. J., Deuster, P., & Venhuis, B. J. (2017). Four experimental stimulants found in sports and weight loss supplements: 2-amino-6-methylheptane (octodrine), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylamylamine (1,3-DMAA) and 1,3-dimethylbutylamine (1,3-DMBA). Clinical Toxicology, 56(6), 421–426. doi:10.1080/15563650.2017.1398328
Di Lorenzo, C., Moro, E., Dos Santos, A., Uberti, F., & Restani, P. (2013). Could 1,3 dimethylamylamine (DMAA) in food supplements have a natural origin? Drug Testing and Analysis, 5(2), 116–121. doi:10.1002/dta.1391
Eliason, M. J., Eichner, A., Cancio, A., Bestervelt, L., Adams, B. D., & Deuster, P. A. (2012). Case reports: Death of active duty soldiers following ingestion of dietary supplements containing 1,3-dimethylamylamine (DMAA). Military Medicine, 177(12), 1455–1459. doi:10.7205/milmed-d-12-00265
Gregory, P. J. (2013). Availability of DMAA supplements despite US Food and Drug Administration action. JAMA Internal Medicine, 173(2), 164–165. doi:10.1001/2013.jamainternmed.724
Kerpel dos Santos, M., Walber, G. B., Kreutz, T., Soares, K., Jacobi Danielli, L., Mariotti, K. d. C., . . . Pereira Limberger, R. (2019). Evaluation of the presence of 1,3-dimethylamylamine in pelargonium leaves and essential oils by mass spectrometric and chromatographic methods. Chromatographia. doi:10.1007/s10337-019-03715-y
Smith, T. B., Staub, B. A., Natarajan, G. M., Lasorda, D. M., & Poornima, I. G. (2014). Acute myocardial infarction associated with dietary supplements containing 1,3-dimethylamylamine and Citrus aurantium. Texas Heart Institute Journal, 41(1), 70–72. doi:10.14503/thij-12-2870
Vorce, S. P., Holler, J. M., Cawrse, B. M., & Magluilo, J. (2011). Dimethylamylamine: A drug causing positive immunoassay results for amphetamines. Journal of Analytical Toxicology, 35(3), 183–187. doi:10.1093/anatox/35.3.183